EATG » News

Hepatitis C Civil Society Declaration launched

At the Hepatitis C Community Summit held on 18-19 April 2017 in Amsterdam, civil society and community organisations from all over Europe launched a declaration to address the urgent need…

EATG is hiring! Executive Assistant position

EATG is looking for an Executive Assistant (EA). The EA will assist the Executive Director and lead the EATG team in its administrative functions. S/he will organize and supervise the…

Do you want to become an EATG intern?

EATG is looking for an intern to support our project based work and office related work. The intern will assist other staff members in their work, but will also get…

Open letter to Gilead Sciences about PrEP by EATG and PrEP in Europe Initiative

Please read and share the letter signed by EATG, as Europe’s transnational HIV treatment and prevention advocacy group, and the PrEP in Europe Initiative (PEI), a partnership of European prevention and…

Ageing with HIV conference follow-up webinar online

The recording from the Ageing with HIV webinar held on 30 March 2017 is now available online:https://www.ageingwithhiv.com/webinars. The webinar is presented by four young persons who attended the Phase 2 conference ‘New…

Interview with Andrej Senih at the Policy Working Group meeting

In this interview, EATG Policy Working Group chair Andrej Senih discusses the topics and outcomes of the meeting the PWG had on 17-18 March 2017. He also explains the significance…

EATG + TAG webinar on tuberculosis treatment is now online

On 13th March 2017, European AIDS Treatment Group and Treatment Action Group (TAG) have jointly organised a webinar on TB Treatment, with special focus on the treatment of drug resistant and multi-drug…

DON’T MISS THIS – CoPE applications now open!

Call for applications: Continuous Patient Education (CoPE) EATG is pleased to announce that a call for applications for CoPE is now open. Please find below detailed information on how to apply…

Webinar – Ageing with HIV conference outcomes – Children and adolescents

AGEING WITH HIV: Conference outcomes - children & adolescents living with HIV The EATG organised a conference about New challenges and unmet needs of children and adolescents living and ageing…

Sitges IX Meeting on Viral Hepatitis – Report now available

In December 2016, EATG together with Alliance for Public Health Ukraine, Eurasian Harm Reduction Network, and Treatment Preparedness Coalition in EECA (ITPCru) convened a meeting on access to direct-acting antivirals…

EATG + TAG webinar on tuberculosis diagnostics now online

On 6th March 2017, European AIDS Treatment Group and Treatment Action Group (TAG) have jointly organised the webinar on TB Diagnostics. The moderator was Evgenia Maron, leader of the EATG TB…

EATG protests against comments by misogynist Polish MEP

Following an incident in the European Parliament, in which Polish MEP Janusz Korwin-Mikke made offensive comments about women and migrants, followed by a Nazi salute, several EATG members felt the…

EATG demands inclusion of TB in WHO global priority list

EATG Chair Jackie Morton, in representation of the European communities of people living with and affected by HIV, sent an open letter to WHO to claim inclusion of tuberculosis in…

EATG + TAG joint webinar on TB treatment

EATG and Treatment Action Group (TAG) invite you to join the webinar on TB Treatment taking place on Monday, 13th March 2017, 15:00-16:30 CET WEBINAR PROGRAMME Topic of the Webinar:…

EUPATI webinar: Presentations now available online

On 30 January 2017 EUPATI held a webinar focused on the revision of the ethical guidelines for biomedical research of the Council for International Organizations of Medical Sciences (CIOMS). David…

Video interviews from CROI2017

The Conference on Retroviruses and Opportunistic Infections, commonly known as CROI was held in Seattle on 13-16 February 2017. It was also preceded by the now traditional Community HIV Cure…

Webinar – Tuberculosis diagnostics and treatment

European AIDS Treatment Group (EATG) and the Treatment Action Group (TAG) are jointly organizing two webinars on TB Diagnostics. We invite you to join the first webinar on TB Diagnostics…

Joint workshop by ILGA-Europe and EATG on HIV

On 9-10 February 2017 ILGA-Europe and EATG jointly implemented a capacity building seminar on the role of LGBTI organisations to address HIV and Sexually Transmitted Infections (STI’s). The training was…

News from CROI2017? Here is your coverage

If you want to follow the news from the Conference on Retroviruses and Opportunistic Infections CROI currently held in Seattle, USA, we recommend the following online reporting sources. EATG, as…

Video reports from the HepHIV conference and the ECDC symposium in Malta

The HIV and HCV testing and surveillance symposium organised by the Maltese Presidency of the EU and ECDC, and the HepHIV2017 Conference organised by HIV in Europe were held in…

10 key messages from civil society and communities to the UNAIDS Global Review Panel

On 28 April 2017, UNAIDS will conduct a Multi-stakeholder consultation to discuss the findings and recommendations of the Global Review Panel (GRP) on the new Operating Model of the UNAIDS…

Complexity of health system in England is ‘holding back progress’ in HIV care

The complexity of the health system in England is holding back progress in meeting the needs of people with HIV, according to a new report from The King’s Fund. The…

BHIVA statement on Wales’ failure to approve PrEP for HIV prevention

26 April 2017 - Although a final decision is yet to be announced, the All Wales Medicines Strategy Group (AWMSG) has indicated that Wales will not join Scotland in recommending…

Providers who prescribe PrEP don’t see most patients increasing risky sexual behavior

Clinicians saw their role as providing sexual health information and options, even if patients stopped using condoms WASHINGTON (April 26, 2017)--A new study examining medical provider attitudes toward prescribing PrEP…

WHO: Guidelines for treatment of drug-susceptible TB and patient care, 2017 update

The World Health Organization (WHO) updated the fourth edition of the Guidelines for treatment of tuberculosis published in 2010. The Global TB Programme of the World Health Organization convened a…

The success of Italy’s community-based approach to naloxone

The provision of naloxone by community-based harm reduction services, as takes place in Italy, is highly important for reducing the harms of opioid drugs, a report suggests. Naloxone is a…

Researchers receive grant to eliminate HIV reservoirs using gene editing

University of Massachusetts Medical School researchers receive amfAR grant to eliminate HIV reservoirs using gene editing Jeremy Luban, Scot Wolfe to explore novel CRISPR/Cpf1 technique HIV, the retrovirus that causes…

Lipid impact on HIV heart disease and antiretroviral impact on lipids

Abstract Research implicates abnormal lipids in incident cardiovascular disease among people with HIV infection. Avoiding high total cholesterol could prevent 43% of myocardial infarctions, according to findings in one large…

More time in HIV care tied to lower mortality

Every additional 10% of time spent in HIV care lowered the risk of death about 10% in a 5.5-year study of more than 44,000 people in the United Kingdom. Lower…

Most HIV/HCV-positive individuals who use drugs willing to start HCV treatment

Nearly three-quarters of HIV/hepatitis C (HCV)-coinfected drug users in Vancouver, Canada, reported willingness to use direct-activing antivirals (DAAs) for HCV infection, a substantial improvement over the willingness of this group…

No consistent pattern of HBV reactivation with direct-acting antivirals for HCV

The largest case review to date of hepatitis B virus (HBV) reactivation associated with direct-acting antiviral (DAA) therapy for chronic hepatitis C virus (HCV) infection found no consistent pattern in…

8-week sofosbuvir-velpatasvir-voxilaprevir less effective for HCV

For patients with chronic hepatitis C virus (HCV) infection, eight weeks of combined sofosbuvir-velpatasvir-voxilaprevir may not be as effective as 12 weeks of only sofosbuvir-velpatasvir, results from two phase 3…

A doctor’s life-enhancing experience of working on a humanitarian TB project in Georgia

Dr. Mark McNicol, a middle grade specialty doctor from Northern Ireland, recently spent 9 months working for Medicines Sans Frontières. In an interview with Medical News Today, he explains that…

The continuum of HIV care: how is Europe doing?

The continuum of HIV care is a framework that enables countries to monitor the effectiveness of their HIV response - from diagnosis towards viral suppression (which means that the virus…

Hepatitis C Civil Society Declaration launched

At the Hepatitis C Community Summit held on 18-19 April 2017 in Amsterdam, civil society and community organisations from all over Europe launched a declaration to address the urgent need…

The WHO European Region remains malaria free

In 2015, the WHO European Region became the first in the world to achieve interruption of indigenous malaria transmission and, in 2016, to be declared malaria free. One year later,…

WHO releases 10-year review report chapter focusing on malaria

A quarter of people taking antiretroviral therapy in Kenya have exhausted current treatment options

Affordable third-line antiretrovirals are urgently needed in resource-limited settings, according to research conducted in Kenya and published in the online edition of AIDS. The study showed that a quarter of…

Anti-drug vaccines could be a game-changer for people battling addiction

The toll of addiction is staggering. Approximately one in seven people who try addictive substances will get hooked, and the abuse of illicit drugs costs the economy $193 billion each…

Research uncovers life-saving benefits in the battle against viruses

At-risk patients, such as those with HIV or transplant recipients, could benefit from potentially life-saving study carried out by a University of Surrey led group of international researchers in a…